Associations between composite cognitive indicator variables) and intention to take up HPV vaccines in the next six months (given efficacies and the market price of $1000–2000 per shot and three shots be taken within six months; N = 542).

*p**p–: Univariately non-significant variables, not considered in the model.ORu: univariate odds ratios.AOR: adjusted OR: odds ratios adjusting for all multivariately significant background variables listed in Table 1, including peer education and UAI with any male partner.95% CI: 95% confidence interval.Composite variables that were not significant in the univariate analysis were not tabulated (number of appropriate response related to knowledge on HPV vaccines, perceived benefits of HPV vaccines preventing and treating diseases related to HPV and perceived self-efficacy on taking up HPV vaccines).